393 related articles for article (PubMed ID: 18308816)
1. Increased cortical inhibition in persons with schizophrenia treated with clozapine.
Daskalakis ZJ; Christensen BK; Fitzgerald PB; Moller B; Fountain SI; Chen R
J Psychopharmacol; 2008 Mar; 22(2):203-9. PubMed ID: 18308816
[TBL] [Abstract][Full Text] [Related]
2. The relationship between cortical inhibition, antipsychotic treatment, and the symptoms of schizophrenia.
Liu SK; Fitzgerald PB; Daigle M; Chen R; Daskalakis ZJ
Biol Psychiatry; 2009 Mar; 65(6):503-9. PubMed ID: 18950746
[TBL] [Abstract][Full Text] [Related]
3. Deficient inhibitory cortical networks in antipsychotic-naive subjects at risk of developing first-episode psychosis and first-episode schizophrenia patients: a cross-sectional study.
Hasan A; Wobrock T; Grefkes C; Labusga M; Levold K; Schneider-Axmann T; Falkai P; Müller H; Klosterkötter J; Bechdolf A
Biol Psychiatry; 2012 Nov; 72(9):744-51. PubMed ID: 22502988
[TBL] [Abstract][Full Text] [Related]
4. Clozapine potentiation of GABA mediated cortical inhibition in treatment resistant schizophrenia.
Kaster TS; de Jesus D; Radhu N; Farzan F; Blumberger DM; Rajji TK; Fitzgerald PB; Daskalakis ZJ
Schizophr Res; 2015 Jul; 165(2-3):157-62. PubMed ID: 25957485
[TBL] [Abstract][Full Text] [Related]
5. Motor circuit abnormalities in first-episode schizophrenia assessed with transcranial magnetic stimulation.
Wobrock T; Schneider-Axmann T; Retz W; Rösler M; Kadovic D; Falkai P; Schneider M
Pharmacopsychiatry; 2009 Sep; 42(5):194-201. PubMed ID: 19724982
[TBL] [Abstract][Full Text] [Related]
6. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
[TBL] [Abstract][Full Text] [Related]
7. Prolonged cortical silent period among drug-naive subjects at ultra-high risk of psychosis.
Tang Y; Zhang T; Edelman B; Zeng B; Zhao S; Li C; Zhuo K; Qian Z; Li H; Guo Q; Cui H; Zhu Y; Jiang L; Li C; Yu D; Wang J
Schizophr Res; 2014 Dec; 160(1-3):124-30. PubMed ID: 25458861
[TBL] [Abstract][Full Text] [Related]
8. Relationship between P50 suppression and the cortical silent period.
Möller B; Light GA; Fitzgerald PB; Snyder JS; Chen R; Daskalakis ZJ
Neuroreport; 2007 Sep; 18(14):1503-6. PubMed ID: 17712283
[TBL] [Abstract][Full Text] [Related]
9. Cortical inhibitory dysfunction in bipolar disorder: a study using transcranial magnetic stimulation.
Levinson AJ; Young LT; Fitzgerald PB; Daskalakis ZJ
J Clin Psychopharmacol; 2007 Oct; 27(5):493-7. PubMed ID: 17873683
[TBL] [Abstract][Full Text] [Related]
10. Paliperidon mediated modification of cortical inhibition.
Prikryl R; Ustohal L; Kucerova HP; Ceskova E
Neuro Endocrinol Lett; 2009; 30(3):396-9. PubMed ID: 19855366
[TBL] [Abstract][Full Text] [Related]
11. Dysfunctional neural plasticity in patients with schizophrenia.
Daskalakis ZJ; Christensen BK; Fitzgerald PB; Chen R
Arch Gen Psychiatry; 2008 Apr; 65(4):378-85. PubMed ID: 18391126
[TBL] [Abstract][Full Text] [Related]
12. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
[TBL] [Abstract][Full Text] [Related]
13. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia.
Farzan F; Barr MS; Levinson AJ; Chen R; Wong W; Fitzgerald PB; Daskalakis ZJ
Brain; 2010 May; 133(Pt 5):1505-14. PubMed ID: 20350936
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic treatment with quetiapine increases the cortical silent period.
Frank E; Landgrebe M; Poeppl TB; Schecklmann M; Kreuzer PM; Prasser J; Rupprecht R; Eichhammer P; Hajak G; Langguth B
Schizophr Res; 2014 Jun; 156(1):128-32. PubMed ID: 24794881
[TBL] [Abstract][Full Text] [Related]
15. Altered cortical processing of motor inhibition in schizophrenia.
Lindberg PG; Térémetz M; Charron S; Kebir O; Saby A; Bendjemaa N; Lion S; Crépon B; Gaillard R; Oppenheim C; Krebs MO; Amado I
Cortex; 2016 Dec; 85():1-12. PubMed ID: 27770667
[TBL] [Abstract][Full Text] [Related]
16. Difference in intracortical inhibition of the motor cortex between cortical myoclonus and focal hand dystonia.
Hanajima R; Okabe S; Terao Y; Furubayashi T; Arai N; Inomata-Terada S; Hamada M; Yugeta A; Ugawa Y
Clin Neurophysiol; 2008 Jun; 119(6):1400-7. PubMed ID: 18387338
[TBL] [Abstract][Full Text] [Related]
17. Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study.
Farzan F; Barr MS; Levinson AJ; Chen R; Wong W; Fitzgerald PB; Daskalakis ZJ
J Neurophysiol; 2010 Sep; 104(3):1339-46. PubMed ID: 20573972
[TBL] [Abstract][Full Text] [Related]
18. Reduced cortical inhibition in first-episode schizophrenia.
Wobrock T; Schneider M; Kadovic D; Schneider-Axmann T; Ecker UK; Retz W; Rösler M; Falkai P
Schizophr Res; 2008 Oct; 105(1-3):252-61. PubMed ID: 18625547
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia.
Bajbouj M; Gallinat J; Niehaus L; Lang UE; Roricht S; Meyer BU
Pharmacopsychiatry; 2004 Mar; 37(2):74-80. PubMed ID: 15048615
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients.
Rossi S; De Capua A; Tavanti M; Calossi S; Polizzotto NR; Mantovani A; Falzarano V; Bossini L; Passero S; Bartalini S; Ulivelli M
Biol Psychiatry; 2009 Jul; 66(1):54-61. PubMed ID: 19368897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
